4.5 Article

Centile estimation for a proportion response variable

Journal

STATISTICS IN MEDICINE
Volume 35, Issue 6, Pages 895-904

Publisher

WILEY
DOI: 10.1002/sim.6748

Keywords

beta inflated distribution; fractional data; GAMLSS; generalised Tobit model; logit skew Student t distribution

Ask authors/readers for more resources

This paper introduces two general models for computing centiles when the response variable Y can take values between 0 and 1, inclusive of 0 or 1. The models developed are more flexible alternatives to the beta inflated distribution. The first proposed model employs a flexible four parameter logit skew Student t (logitSST) distribution to model the response variable Y on the unit interval (0, 1), excluding 0 and 1. This model is then extended to the inflated logitSST distribution for Y on the unit interval, including 1. The second model developed in this paper is a generalised Tobit model for Y on the unit interval, including 1. Applying these two models to (1-Y) rather than Y enables modelling of Y on the unit interval including 0 rather than 1. An application of the new models to real data shows that they can provide superior fits. Copyright (c) 2015 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease

Salvatore Petta, Giada Sebastiani, Mauro Vigano, Javier Ampuero, Vincent Wai-Sun Wong, Jerome Boursier, Annalisa Berzigotti, Elisabetta Bugianesi, Anna Ludovica Fracanzani, Calogero Camma, Marco Enea, Marraud des Grottes, Vito Di Marco, Ramy Younes, Aline Keyrouz, Sergio Mazzola, Yuly Mendoza, Grazia Pennisi, Manuel Romero-Gomez, Antonio Craxi, Victor de Ledinghen

Summary: The study found that in patients with NAFLD and compensated advanced chronic liver disease, baseline liver stiffness measurements and their changes can be used to identify patients at risk for liver-related events and mortality.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Efficacy of lumen-apposing metal stents or self-expandable metal stents for endoscopic ultrasound-guided choledochoduodenostomy: a systematic review and meta-analysis

Arnaldo Amato, Emanuele Sinagra, Ciro Celsa, Marco Enea, Andrea Buda, Filippo Vieceli, Lucia Scaramella, Paul Belletrutti, Alessandro Fugazza, Calogero Camma, Franco Radaelli, Alessandro Repici, Andrea Anderloni

Summary: This meta-analysis showed that lumen-apposing metal stents (LAMS) and self-expandable metal stents (SEMS) are comparable in terms of efficacy for endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS). Clinical and technical success, post-procedure adverse events, and reintervention rates were similar between LAMS and SEMS use; however, adverse events require further investigation.

ENDOSCOPY (2021)

Article Multidisciplinary Sciences

Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use

Bianca Magro, Valentina Zuccaro, Luca Novelli, Lorenzo Zileri, Ciro Celsa, Federico Raimondi, Mauro Gori, Giulia Camma, Salvatore Battaglia, Vincenzo Giuseppe Genova, Laura Paris, Matteo Tacelli, Francesco Antonio Mancarella, Marco Enea, Massimo Attanasio, Michele Senni, Fabiano Di Marco, Luca Ferdinando Lorini, Stefano Fagiuoli, Raffaele Bruno, Calogero Camma, Antonio Gasbarrini

Summary: A simple clinical prediction rule was developed to identify in-hospital mortality risk for COVID-19 patients. With seven independent risk factors, the prediction rule showed good discrimination and calibration in both the derivation and validation cohorts.

PLOS ONE (2021)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

Victor Sapena, Marco Enea, Ferran Torres, Ciro Celsa, Jose Rios, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Marino, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kevin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G. Singal, Caitlin Murphy, Mohamed Kohla, Chiara Masetti, Jean-Francois Dufour, Nicolas Merchante, Luisa Cavalletto, Liliana L. C. Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Camma, Jordi Bruix, Giuseppe Cabibbo, Maria Reig

Summary: This meta-analysis assessed the risk of HCC recurrence following DAA administration in HCV-related cirrhosis and HCC patients. Results showed an increased risk of recurrence and death in patients treated with DAAs, but no significant difference was observed in comparison to the DAA-unexposed group. Factors influencing recurrence included alpha-fetoprotein levels, pre-DAA recurrence history, patient performance status, and tumor burden.
Article Gastroenterology & Hepatology

Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis

Grazia Pennisi, Marco Enea, Manuel Romero-Gomez, Mauro Vigano, Elisabetta Bugianesi, Vincent W. -s Wong, Anna Ludovica Fracanzani, Giada Sebastiani, Jerome Boursier, Annalisa Berzigotti, Mohammed Eslam, Javier Ampuero, Amine Benmassaoud, Claudia La Mantia, Yuly P. Mendoza, Jacob George, Antonio Craxi, Calogero Camma', Victor de Ledinghen, Salvatore Petta

Summary: The occurrence of extrahepatic events (EHE) in patients with non-alcoholic fatty liver disease (NAFLD) is relevant and increases according to the severity of liver fibrosis, while the risk of liver-related events (LRE) is low in patients with mild fibrosis.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease

Grazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, Marco Enea, Manuel Romero-Gomez, Mauro Vigano, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Anna Ludovica Fracanzani, Giada Sebastiani, Annalisa Berzigotti, Francesca Di Salvo, Antonino Giulio Giannone, Claudia La Mantia, Giulia Lupo, Rossana Porcasi, Federica Vernuccio, Rossella Zito, Vito Di Marco, Calogero Camma, Antonio Craxi, Victor de Ledinghen, Stefania Grimaudo, Salvatore Petta

Summary: The presence of a cholestatic pattern in patients with NAFLD predicts a higher risk of major liver-related outcomes independently from other features of liver disease.

LIVER INTERNATIONAL (2022)

Article Medicine, General & Internal

Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC

Roberto Cannella, Carla Camma, Francesco Matteini, Ciro Celsa, Paolo Giuffrida, Marco Enea, Albert Comelli, Alessandro Stefano, Calogero Camma, Massimo Midiri, Roberto Lagalla, Giuseppe Brancatelli, Federica Vernuccio

Summary: This study explored the potential of radiomics on gadoxetate disodium-enhanced MRI for predicting hepatocellular carcinoma (HCC) response after transarterial embolization (TAE). The results showed that radiomics models based on gadoxetate disodium-enhanced MRI can achieve good performance in predicting the response of HCCs treated with TAE.

DIAGNOSTICS (2022)

Article Gastroenterology & Hepatology

AGILE 3+Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD

Grazia Pennisi, Marco Enea, Alessandra Pandolfo, Ciro Celsa, Michela Antonucci, Carlo Ciccioli, Giuseppe Infantino, Claudia La Mantia, Stefanie Parisi, Adele Tulone, Vito Di Marco, Antonio Craxi, Calogero Camma, Salvatore Petta

Summary: This study aimed to assess the accuracy of AGILE 3+, a score based on various factors, for the diagnosis of advanced fibrosis and the prediction of liver-related events in patients with NAFLD. The results showed that AGILE 3+ had higher diagnostic performance compared to FIB-4 and LSM.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model

Francesco Vizzutti, Ciro Celsa, Vincenza Calvaruso, Marco Enea, Salvatore Battaglia, Laura Turco, Marco Senzolo, Silvia Nardelli, Roberto Miraglia, Davide Roccarina, Claudia Campani, Dario Saltini, Cristian Caporali, Federica Indulti, Stefano Gitto, Alberto Zanetto, Gabriele Di Maria, Marcello Bianchini, Maddalena Pecchini, Silvia Aspite, Chiara Di Bonaventura, Michele Citone, Tomas Guasconi, Fabrizio Di Benedetto, Umberto Arena, Fabrizio Fanelli, Luigi Maruzzelli, Oliviero Riggio, Patrizia Burra, Antonio Colecchia, Erica Villa, Fabio Marra, Calogero Camma, Filippo Schepis

Summary: The aim of this study was to develop and validate a multivariable model for an accurate prediction of mortality in older adults. The results showed that creatinine and sodium levels are useful predictors for decision making in older adults. Further efforts to update the prediction model with larger sample size are warranted.

HEPATOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis

Grazia Pennisi, Ciro Celsa, Marco Enea, Marco Vaccaro, Vito Di Marco, Carlo Ciccioli, Giuseppe Infantino, Claudia La Mantia, Stefanie Parisi, Federica Vernuccio, Antonio Craxi, Calogero Camma, Salvatore Petta

Summary: This study aimed to quantify histological improvement and its risk factors in NASH patients enrolled in the placebo arms of RCTs, and to compare the effect of investigational drugs for NASH on histological outcomes. The meta-analysis on placebo arms showed NASH resolution without worsening of fibrosis in 17% of patients and at least 1 stage improvement of fibrosis without worsening of NASH in 21% of patients. Phase 3 RCTs, older age, and higher AST levels were associated with progression of liver disease. Network meta-analysis suggested that Semaglutide, Pioglitazone alone or in combination with Vitamin E, Aldafermin, Lanifibranor, and Obeticholic acid were the most effective interventions for NASH improvement and fibrosis reduction.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Letter Gastroenterology & Hepatology

Letter to the Editor: Predicting mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis-Does novelty supplant the standard? Reply

Francesco Vizzutti, Ciro Celsa, Salvatore Battaglia, Roberto Miraglia, Marco Enea, Fabio Marra, Cristian Caporali, Calogero Camma, Filippo Schepis

HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

Reply

Francesco Vizzutti, Ciro Celsa, Salvatore Battaglia, Roberto Miraglia, Marco Enea, Fabio Marra, Antonio Colecchia, Calogero Camma, Filippo Schepis

HEPATOLOGY (2023)

Article Oncology

Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation

Simone Lasagni, Filippo Leonardi, Alessandra Pivetti, Lorenza Di Marco, Federico Ravaioli, Matteo Serenari, Stefano Gitto, Rosina Maria Critelli, Fabiola Milosa, Adriana Romanzi, Serena Mancarella, Francesco Dituri, Mattia Riefolo, Barbara Catellani, Paolo Magistri, Dante Romagnoli, Ciro Celsa, Marco Enea, Nicola de Maria, Filippo Schepis, Antonio Colecchia, Calogero Camma, Matteo Cescon, Antonietta d'Errico, Fabrizio di Benedetto, Gianluigi Giannelli, Maria Luz Martinez-Chantar, Erica Villa

Summary: By analyzing the clinical, histopathological, and biological characteristics of patients undergoing liver transplantation, this study identified the expression of endothelial angiopoietin-2 as a powerful independent predictor of post-transplant tumor recurrence and mortality. This marker could assist in more accurate assessment and prioritization of patients before liver transplantation.

FRONTIERS IN ONCOLOGY (2022)

Letter Gastroenterology & Hepatology

Reply

Francesco Vizzutti, Ciro Celsa, Salvatore Battaglia, Roberto Miraglia, Marco Enea, Fabio Marra, Cristian Capporali, Calogero Camma, Filippo Schepis

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease

Grazia Pennisi, Rosaria Maria Pipitone, Marco Enea, Antonio De Vincentis, Salvatore Battaglia, Vito Di Marco, Vincenzo Di Martino, Federica Spatola, Federica Tavaglione, Umberto Vespasiani-Gentilucci, Rossella Zito, Stefano Romeo, Calogero Camma, Antonio Craxi, Stefania Grimaudo, Salvatore Petta

Summary: This article assessed the ability of a composite score based on clinical features, metabolic comorbidities, and genetic variants to predict the outcome of patients with nonalcoholic fatty liver disease (NAFLD). The study found that the scoring system had an adequate ability to predict the outcome of NAFLD patients and was associated with the occurrence of severe liver disease.

HEPATOLOGY COMMUNICATIONS (2022)

No Data Available